[Immunomodulin efficacy in treatment of celiac disease in children].

Abstract

Overall forty patients with celiac disease who ranged from 1 to 10 years old were kept under medical observation. Measured in the above patient population were the following parameters for cellular immunity: the content of T-, B- lymphocytes and of subpopulation of T-lymphocytes. In all patients, the content of T- and B-lymphocytes was reduced. 18 children received immunomodulin as a corrective measure in injections and a supporting dose in tablets over two months. There was an improvement in clinical symptomatology of the condition that was particularly apparent in the long-term results in the presence of increased values for T-lymphocytes in the group of patients having received immunomodulin against the background of basic therapy.

• Authors: A T Kamilova
• Journal: Likars'ka sprava (Lik Sprava) Issue 6 Pg. 107-8 (Sep 2000) ISSN: 1019-5297 [Print] Ukraine
• Vernacular Title: Effektivnost' immunomodulina v lechenii tseliakii u deteĭ.
• PMID: 11455921 (Publication Type: Clinical Trial, English Abstract, Journal Article)

Chemical References

• Adjuvants, Immunologic
• Organic Chemicals
• Suppressor Factors, Immunologic
• immunomodulin

Topics

• Adjuvants, Immunologic (therapeutic use)
• B-Lymphocytes (metabolism, pathology)
• Celiac Disease (drug therapy, immunology)
• Child
• Child, Preschool
• Humans
• Infant
• Lymphocyte Count
• Organic Chemicals
• Suppressor Factors, Immunologic (metabolism)
• T-Lymphocytes (metabolism, pathology)